10-K Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0000950170-24-021155`
Period End Date	20231231
Filing Date	20240227
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	tmdx-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 52 Cash Flow Statement 110 Stockholders Equity 30 Comprehensive Income 17

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash	`Cash`	$394.81M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$201.18M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$63.58M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$27.61M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	$44.23M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Inventory	`InventoryNet`	$20.61M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.03M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.90M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$510.65M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$252.29M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	32.67M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	32.14M	shares	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$19.22M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$173.94M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	32.14M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	32.67M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$5.13M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$6.55M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Goodwill	`Goodwill`	$11.99M	USD	Point-in-time
Acquired intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.35M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$62.00K	USD	Point-in-time
Total assets	`Assets`	$706.05M	USD	Point-in-time
Total assets	`Assets`	$277.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.34M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.72M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$38.22M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$18.64M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$241.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.96M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.44M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$54.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.66M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$447.14M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$58.70M	USD	Point-in-time
Long-term debt, net	`OtherLongTermDebtNoncurrent`	$59.06M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.71M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$7.42M	USD	Point-in-time
Total liabilities	`Liabilities`	$89.77M	USD	Point-in-time
Total liabilities	`Liabilities`	$568.85M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 32,670,803 shares and 32,141,368 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$641.11M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 32,670,803 shares and 32,141,368 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	`CommonStockValue`	$666.28M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-199.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-225.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-478.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-503.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.89M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$137.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$187.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$67.85M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$277.15M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$706.05M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`Revenues`	$241.62M	USD	Annual
Total revenue	`Revenues`	$30.26M	USD	Annual
Total revenue	`Revenues`	$93.46M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$87.53M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$28.19M	USD	Annual
Total cost of revenue	`CostOfRevenue`	$9.10M	USD	Annual
Gross profit	`GrossProfit`	$154.09M	USD	Annual
Gross profit	`GrossProfit`	$65.27M	USD	Annual
Gross profit	`GrossProfit`	$21.16M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$26.81M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$22.30M	USD	Annual
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$36.05M	USD	Annual
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$38.28M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$69.90M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$119.55M	USD	Annual
Total operating expenses	`OperatingExpenses`	$60.59M	USD	Annual
Total operating expenses	`OperatingExpenses`	$96.71M	USD	Annual
Total operating expenses	`OperatingExpenses`	$182.82M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-28.73M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-39.43M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-31.44M	USD	Annual
Interest expense	`InterestExpense`	$3.87M	USD	Annual
Interest expense	`InterestExpense`	$3.73M	USD	Annual
Interest expense	`InterestExpense`	$10.79M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$12.85M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-1.00M	USD	Annual
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-877.00K	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-4.75M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$2.06M	USD	Annual
Total other income (expense), net	`NonoperatingIncomeExpense`	$-4.73M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-26.67M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.16M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.18M	USD	Annual
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$36.00K	USD	Annual
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$66.00K	USD	Annual
(Provision) benefit for income taxes	`CurrentIncomeTaxExpenseBenefit`	$-1.64M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.03M	USD	Annual
Net loss	`NetIncomeLoss`	$-36.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-44.22M	USD	Annual
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-1.60	USD	Annual
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-1.23	USD	Annual
Net loss per share attributable to common stockholders, basic	`EarningsPerShareBasic`	$-0.77	USD	Annual
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-1.60	USD	Annual
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-0.77	USD	Annual
Net loss per share attributable to common stockholders, diluted	`EarningsPerShareDiluted`	$-1.23	USD	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	32.52M	shares	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	29.56M	shares	Annual
Weighted average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.62M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.56M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.52M	shares	Annual
Weighted average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.62M	shares	Annual

Cash Flow Statement 110 line items

Line Item	Tag	Value	Unit	Period
Convertible senior notes, issuance costs paid	`PaymentsOfDebtIssuanceCosts`	$14.62M	USD	Annual
Net loss	`ProfitLoss`	$-36.23M	USD	Annual
Net loss	`ProfitLoss`	$-44.22M	USD	Annual
Net loss	`ProfitLoss`	$-25.03M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.82M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$8.18M	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$3.48M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$19.79M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$6.88M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$10.32M	USD	Annual
Acquired in-process research and development expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$27.21M	USD	Annual
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.66M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-575.00K	USD	Annual
Loss on sale of marketable securities	`LossOnSaleOfInvestments`	$107.00K	USD	Annual
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$540.00K	USD	Annual
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$2.13M	USD	Annual
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$465.00K	USD	Annual
Non-cash lease expense	`NonCashLeaseExpense`	$1.04M	USD	Annual
Non-cash lease expense	`NonCashLeaseExpense`	$829.00K	USD	Annual
Non-cash lease expense	`NonCashLeaseExpense`	$717.00K	USD	Annual
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$1.36M	USD	Annual
Net amortization of premiums on marketable securities	`AmortizationOfDebtDiscountPremium`	$381.00K	USD	Annual
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-1.13M	USD	Annual
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-928.00K	USD	Annual
Unrealized foreign currency transaction (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$342.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.68M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-840.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$33.82M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$4.89M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$8.02M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$28.09M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.52M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.15M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.10M	USD	Annual
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$54.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.27M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.09M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.96M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.44M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$14.25M	USD	Annual
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$4.88M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$83.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$7.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.57M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$255.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$236.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.03M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.86M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-45.82M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$151.85M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.52M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.91M	USD	Annual
Purchase of business, net of cash acquired	`PaymentsToAcquireBusinessesGross`	$14.89M	USD	Annual
Purchase of in-process research and development assets	`PaymentsToAcquireInProcessResearchAndDevelopment`	$27.21M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.50M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$72.02M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$76.92M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$104.81M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-193.95M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$54.51M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$29.27M	USD	Annual
Proceeds from issuance of convertible senior notes, net of issuance costs paid of $14,620	`ProceedsFromConvertibleDebt`	$445.38M	USD	Annual
Purchases of capped calls related to convertible senior notes	`PaymentsForCappedCallsConvertibleSeniorNotes`	$52.07M	USD	Annual
Proceeds from issuance of long-term debt, net of issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$58.51M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$36.05M	USD	Annual
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions and issuance costs paid	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissionsAndIssuanceCostsPaid`	$139.85M	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$974.00K	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$6.16M	USD	Annual
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$4.67M	USD	Annual
Proceeds from issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$438.00K	USD	Annual
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$509.00K	USD	Annual
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$419.00K	USD	Annual
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$955.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$167.93M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.39M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$400.42M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-797.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.02M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$999.00K	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$193.63M	USD	Annual
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$175.60M	USD	Annual
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$3.33M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$8.09M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$3.26M	USD	Annual
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$2.13M	USD	Annual
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$4.57M	USD	Annual
Transfers of inventory to property, plant and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.82M	USD	Annual
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$62.00K	USD	Annual
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.20M	USD	Annual
Purchases of property, plant and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$2.45M	USD	Annual
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$2.17M	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$394.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$201.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.58M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$26.08M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$201.68M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$395.31M	USD	Point-in-time
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.08M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs	`DiscountsAndIssuanceCosts`	$676.00K	USD	Annual
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.38M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.16M	USD	Annual
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.67M	USD	Annual
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$974.00K	USD	Annual
Issuance of common stock upon the exercise of common stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	493,935.00	shares	Annual
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$955.00K	USD	Annual
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$509.00K	USD	Annual
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$419.00K	USD	Annual
Issuance of common stock in public offering, net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$139.85M	USD	Annual
Issuance of common stock in connection with exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$438.00K	USD	Annual
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$10.32M	USD	Annual
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$6.88M	USD	Annual
Stock-based compensation expense	`AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$19.79M	USD	Annual
Purchases of capped calls related to convertible senior notes	`PurchasesOfCappedCallsRelatedToConvertibleSeniorNotes`	$-52.07M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$26.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-73.00K	USD	Annual
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	Annual
Unrealized gains (losses) on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-47.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-25.03M	USD	Annual
Net loss	`NetIncomeLoss`	$-36.23M	USD	Annual
Net loss	`NetIncomeLoss`	$-44.22M	USD	Annual
Balance	`StockholdersEquity`	$103.89M	USD	Point-in-time
Balance	`StockholdersEquity`	$137.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$187.38M	USD	Point-in-time
Balance	`StockholdersEquity`	$67.85M	USD	Point-in-time

Comprehensive Income 17 line items

Line Item	Tag	Value	Unit	Period
Net Income (Loss)	`NetIncomeLoss`	$-25.03M	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	-	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-36.23M	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-44.22M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$26.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-73.00K	USD	Annual
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$36.00K	USD	Annual
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-47.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-37.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-93.00K	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$26.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-25.00M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-36.27M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-44.31M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.